Guangdong VTR Bio-Tech Co (SZSE:300381) Total Liabilities : ¥280.8 Mil (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Guangdong VTR Bio-Tech Co Total Liabilities?

Guangdong VTR Bio-Tech Co's Total Liabilities for the quarter that ended in Mar. 2024 was ¥280.8 Mil.

Guangdong VTR Bio-Tech Co's quarterly Total Liabilities increased from Sep. 2023 (¥270.08 Mil) to Dec. 2023 (¥359.79 Mil) but then declined from Dec. 2023 (¥359.79 Mil) to Mar. 2024 (¥280.75 Mil).

Guangdong VTR Bio-Tech Co's annual Total Liabilities declined from Dec. 2021 (¥1,431.93 Mil) to Dec. 2022 (¥356.26 Mil) but then increased from Dec. 2022 (¥356.26 Mil) to Dec. 2023 (¥359.79 Mil).

Guangdong VTR Bio-Tech Co Total Liabilities Historical Data

The historical data trend for Guangdong VTR Bio-Tech Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guangdong VTR Bio-Tech Co Total Liabilities Chart

Guangdong VTR Bio-Tech Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

1,789.32

1,409.30

1,431.93

356.26

359.79

Guangdong VTR Bio-Tech Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															325.63	271.35	270.08	359.79	280.75

Guangdong VTR Bio-Tech Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Guangdong VTR Bio-Tech Co's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	308.863	+	(0	+	50.923
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	359.8

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	3094.935	-	2735.149
	=	359.8

Guangdong VTR Bio-Tech Co's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	228.728	+	(0	+	52.026
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	280.8

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	2953.504	-	2672.75
	=	280.8

Guangdong VTR Bio-Tech Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Guangdong VTR Bio-Tech Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Guangdong VTR Bio-Tech Co (SZSE:300381) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Guangdong VTR Bio-Tech Co Ltd (SZSE:300381) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 8, Pingbei 1st Road, Nanping Science and Technology Industrial Park, Guangdong Province, Zhuhai, CHN, 519060

Website

http://www.yiduoli.com

Guangdong VTR Bio-Tech Co Ltd is a China based biotechnology company. It is engaged in the research, development, production, sales and service of biopharmaceuticals, bio-enzyme preparations, microbial preparations, functional additives and green biological manufacturing engineering. The company's products include Wittler tributyrin, temperature glucose oxidase, Mildew, VTR-TH26 glucoamylase, Sorghum specific compound enzyme, and others. It sells its products in China, and also exports it to various other countries.

Executives

Feng Guo Hua	Executives
Du Hong Fang	Executives
Chen Shao Mei	Directors, executives
Zhou De Rong	Directors, Directors, and Executives
Li Hong Bing	Director
Ding Si Liang	Executives
Liu Dong Xue	Director
Qin Qiang	Director
Dai Qing Ying	Supervisors

Guangdong VTR Bio-Tech Co (SZSE:300381) Headlines

No Headlines